The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Effect of metformin on the epigenetic age of peripheral blood in patients with diabetes mellitus
Abstract
Background: Metformin has been proven to have an antiaging effect. However, studies on how metformin affects global epigenetic regulation and its effect on the epigenetic clock in diabetes mellitus (DM) patients are limited. This study aims to investigate the impact of metformin on the epigenetic age in subjects with type 2 DM. Results: We collected the peripheral blood of the metformin group and the no-metformin group of the 32 DM patients. Three previously established epigenetic clocks (Hannum, Horvath, and DNAmPhenoAge) were used to estimate the epigenetic age acceleration of the two groups. We defined biological age acceleration for each group by comparing the estimated biological age with the chronological age. Results were presented as follows: 1) all three epigenetic clocks were strongly correlated with chronological age. 2) We found a strong association between metformin intake and slower epigenetic aging by Horvath’s clock and Hannum’s clock. Conclusions: Here, we found an association between metformin intake and slower epigenetic aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results show that pharmacological interventions, particularly anti-TNF therapies26,27 and metformin28–30, consistently induced strong changes in DNAm biomarkers, more so than supplements, diets or lifestyle changes.”
From Responsiveness of epigenetic aging biomarkers to longevity interventions in humans (2026) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation GrimAge strongly predicts lifespan and healthspan
Lu, A. T., Quach, A., Wilson, J. G., Reiner, A. P., Aviv, A., Raj, K., Hou, L., Baccarelli, A. A., Li, Y., Stewart, J. D., et al. (2019) · Aging · doi:10.18632/aging.101684 · Cited by 2,540
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 2×
“Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age related pathologies [22].”
BackgroundMetformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
DNA methylation-based measures of biological age: meta-analysis predicting time to death
Chen, B. H., Marioni, R. E., Colicino, E., Peters, M. J., Ward-Caviness, C. K., Tsai, P.-C., Roetker, N. S., Just, A. C., Demerath, E. W., Guan, W., et al. (2016) · Aging · doi:10.18632/aging.101020 · Cited by 1,126
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096 · cited 2×
“Recent advances revealed that this drug, in addition to its glucose-lowering action, might be promising target for aging [19] [20] [21] [22] [23].”
BackgroundEffects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J. (2014) · Biochemical Journal · doi:10.1042/bj20140620 · Cited by 661
Reversal of epigenetic aging and immunosenescent trends in humans.
Fahy, G. M., Brooke, R. T., Watson, J. P., Good, Z., Vasanawala, S. S., Maecker, H., Leipold, M. D., Lin, D. T. S., Kobor, M. S., & Horvath, S. (2019) · Aging Cell · doi:10.1111/acel.13028 · Cited by 477
Howell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408 · cited 1×
“Especially for aging, metformin can lead to decreased insulin levels, decreased IGF-1 signaling pathway [29] [30], and mTOR inhibition [31] [32], inhibition of mitochondrial complex 1 in the electron transport chain and reduction of endogenous reactive oxygen species (ROS) production [33] [34], activation of AMPK [32]…”
BackgroundMetformin Activates a Duodenal Ampk-Dependent Pathway to Lower Hepatic Glucose Production in Rats
Duca, F. A., Côté, C. D., Rasmussen, B. A., Zadeh-Tahmasebi, M., Rutter, G. A., Filippi, B. M., & Lam, T. K. T. (2015) · Nature Medicine · doi:10.1038/nm.3787 · Cited by 402
Hannon, E., Dempster, E., Viana, J., Burrage, J., Smith, A. R., Macdonald, R., St Clair, D., Mustard, C., Breen, G., Therman, S., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1041-x · Cited by 349
Flagged first, then by citations
Research works printed but not linked: 40
- Admasu, 2018, Drug synergy slows aging and improves healthspan through IGF and SREBP lipid signaling, Dev. Cell., 47, 67, 10.1016/j.devcel.2018.09.001 · DOI
- Banerjee, 2016, Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter, J. Mol. Med., 94, 1397, 10.1007/s00109-016-1455-7 · DOI
- Bell, 2012, Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population, PLoS Genet., 8, e1002629, 10.1371/journal.pgen.1002629 · DOI
- Benayoun, 2015, Epigenetic regulation of ageing: Linking environmental inputs to genomic stability, Nat. Rev. Mol. Cell. Biol., 16, 593, 10.1038/nrm4048 · DOI · Paper page
- Cabreiro, 2013, Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism, Cell., 153, 228, 10.1016/j.cell.2013.02.035 · DOI · Paper page
- Daniel, 2018, T cell epigenetic remodeling and accelerated epigenetic aging are linked to long-term immune alterations in childhood cancer survivors, Clin. Epigenetics, 10, 138, 10.1186/s13148-018-0561-5 · DOI
- Dhahbi, 2005, Identification of potential caloric restriction mimetics by microarray profiling, Physiol. Genomics, 23, 343, 10.1152/physiolgenomics.00069.2005 · DOI · Paper page
- Dziewulska, 2020, SCD1 regulates the AMPK/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle, J. Cell. Physiol., 235, 1129, 10.1002/jcp.29026 · DOI
- El Khoury, 2019, Systematic underestimation of the epigenetic clock and age acceleration in older subjects, Genome Biol., 20, 283, 10.1186/s13059-019-1810-4 · DOI
- Elbere, 2018, Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals, Clin. Epigenetics, 10, 156, 10.1186/s13148-018-0593-x · DOI
- Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766 · DOI · Paper page
- García-Calzón, 2017, Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver, Clin. Epigenetics, 9, 102, 10.1186/s13148-017-0400-0 · DOI
- Gibson, 2019, A meta-analysis of genome-wide association studies of epigenetic age acceleration, PLoS Genet., 15, e1008104, 10.1371/journal.pgen.1008104 · DOI
- Gwinn, 2008, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell., 30, 214, 10.1016/j.molcel.2008.03.003 · DOI · Paper page
- Hannum, 2013, Genome-wide methylation profiles reveal quantitative views of human aging rates, Mol. Cell., 49, 359, 10.1016/j.molcel.2012.10.016 · DOI · Paper page
- Horvath, 2013, DNA methylation age of human tissues and cell types, Genome Biol., 14, R115, 10.1186/gb-2013-14-10-r115 · DOI · Paper page
- Horvath, 2015, Accelerated epigenetic aging in Down syndrome, Aging Cell., 14, 491, 10.1111/acel.12325 · DOI
- Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell., 115, 577, 10.1016/s0092-8674(03)00929-2 · DOI · Paper page
- Inzucchi, 2002, Oral antihyperglycemic therapy for type 2 diabetes: Scientific review, JAMA, 287, 360, 10.1001/jama.287.3.360 · DOI
- Jylhävä, 2017, Biological age predictors, EBioMedicine, 21, 29, 10.1016/j.ebiom.2017.03.046 · DOI · Paper page
- Karnewar, 2018, Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction, Biochim. Biophys. Acta. Mol. Basis Dis., 1864, 1115, 10.1016/j.bbadis.2018.01.018 · DOI · Paper page
- Kresovich, 2019, Methylation-based biological age and breast cancer risk, J. Natl. Cancer Inst., 111, 1051, 10.1093/jnci/djz020 · DOI
- Lee, 2016, Forensic DNA methylation profiling from evidence material for investigative leads, BMB Rep., 49, 359, 10.5483/bmbrep.2016.49.7.070 · DOI
- Levine, 2018, An epigenetic biomarker of aging for lifespan and healthspan, Aging, 10, 573, 10.18632/aging.101414 · DOI · Paper page
- Madeo, 2019, Caloric restriction mimetics against age-associated disease: Targets, mechanisms, and therapeutic potential, Cell. Metab., 29, 592, 10.1016/j.cmet.2019.01.018 · DOI · Paper page
- Maegawa, 2010, Widespread and tissue specific age-related DNA methylation changes in mice, Genome Res., 20, 332, 10.1101/gr.096826.109 · DOI · Paper page
- Marioni, 2015, DNA methylation age of blood predicts all-cause mortality in later life, Genome Biol., 16, 25, 10.1186/s13059-015-0584-6 · DOI · Paper page
- Marioni, 2015, The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936, Int. J. Epidemiol., 44, 1388, 10.1093/ije/dyu277 · DOI
- Na, 2013, Mechanism of metformin: Inhibition of DNA damage and proliferative activity in Drosophila midgut stem cell, Mech. Ageing Dev., 134, 381, 10.1016/j.mad.2013.07.003 · DOI
- Nguyen, 2019, Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity, Sci. Rep., 9, 2003, 10.1038/s41598-019-38778-2 · DOI
- Nwanaji-Enwerem, 2018, Multi-tissue DNA methylation age: Molecular relationships and perspectives for advancing biomarker utility, Ageing Res. Rev., 45, 15, 10.1016/j.arr.2018.04.005 · DOI
- Ong, 2018, Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming, Ageing Res. Rev., 43, 64, 10.1016/j.arr.2018.02.004 · DOI
- Pernicova, 2014, Metformin-mode of action and clinical implications for diabetes and cancer, Nat. Rev. Endocrinol., 10, 143, 10.1038/nrendo.2013.256 · DOI
- Rakyan, 2010, Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains, Genome Res., 20, 434, 10.1101/gr.103101.109 · DOI
- Sae-Lee, 2018, Dietary intervention modifies DNA methylation age assessed by the epigenetic clock, Mol. Nutr. Food Res., 62, e1800092, 10.1002/mnfr.201800092 · DOI · Paper page
- Vazirpanah, 2019, mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?, Ann. Rheum. Dis., 78, 663, 10.1136/annrheumdis-2018-214656 · DOI
- Wagner, 2017, Epigenetic aging clocks in mice and men, Genome Biol., 18, 107, 10.1186/s13059-017-1245-8 · DOI
- Yang, 2020, The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis, Pharmacol. Res., 151, 104588, 10.1016/j.phrs.2019.104588 · DOI · Paper page
- Zhang, 2016, Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice, Blood, 128, 2774, 10.1182/blood-2015-11-683490 · DOI
- Zhong, 2017, Metformin alters DNA methylation genome-wide via the H19/SAHH axis, Oncogene, 36, 2345, 10.1038/onc.2016.391 · DOI · Paper page
Cited by
Sorted by citations
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
Sehgal, R., Borrus, D., Armstrong, J. F., Gonzalez, J., Kasamoto, J., Markov, Y., Priyanka, A., Smith, R., Carreras-Gallo, N., Lasky-Su, J., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04562-9 · Cited by 31
Metadata
- Authors
- Li, M., Bao, L., Zhu, P., & Wang, S.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2022-09-26
- Volume
- 13
- ISSN
- 1664-8021
- PMC
- PMC9548538
- Cited by
- 21
- References
- 13
- Funders
- National Key Research and Development Program of China
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review